Evidence map›Paper›PMID 28082345›Full record

ArticleHaematologica2017

Hugues Beauchemin, Peiman Shooshtarizadeh, Charles Vadnais, Lothar Vassen, Yves D Pastore, Tarik Möröy

Open access · goldAbstract read
In one paragraph

Article in Haematologica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. GATA1 in Normal and Pathologic Megakaryopoiesis and Platelet Development.Advances in experimental medicine and biology · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Anti-apoptoticHaematologica · 2019
    Article
  12. Induction of differentiation of human stem cellsWorld journal of stem cells · 2019
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Hugues BeaucheminInstitut de Recherches Cliniques de Montréal, IRCM, QC, Canada.
Peiman ShooshtarizadehInstitut de Recherches Cliniques de Montréal, IRCM, QC, Canada.
Charles VadnaisInstitut de Recherches Cliniques de Montréal, IRCM, QC, Canada.
Lothar VassenInstitut de Recherches Cliniques de Montréal, IRCM, QC, Canada.
Yves D PastoreDépartement de Pédiatrie, Service d'Hématologie et Oncologie, CHU Ste-Justine, Montréal, QC, Canada.
Tarik MöröyInstitut de Recherches Cliniques de Montréal, IRCM, QC, Canada tarik.moroy@ircm.qc.ca.
Montreal Clinical Research Institute · CACentre Hospitalier Universitaire Sainte-Justine · CAUniversité de Montréal · CA

Funding

CIHR MOP – 111247
6 · The paper itself

Abstract

Mutations in

Indexed as

Signal TransductionActinsAnimalsCell DifferentiationCells, CulturedCytoskeletonGene Expression ProfilingGenetic Association StudiesIntegrinsMegakaryocytesMiceMice, KnockoutMicrotubulesPhenotypePlatelet CountProtein Kinase InhibitorsActinsGfi1b protein, mouseIntegrinsProtein Kinase InhibitorsProto-Oncogene ProteinsRepressor Proteins

Identifiers

PMID28082345
PMCPMC5394960
OpenAlexW2573426943

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.